An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

A nasal spray that's having life-changing impacts on people living with depression is set to be listed on the PBS, slashing ...

A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

A nasal spray that's changed the lives of people living with chronic depression is set to be listed on the PBS.

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...

A new nasal spray, that’s chemically similar to Ketamine, is being added to the Pharmaceutical Benefits Scheme, for adults ...

Indivior PLC’s recovery hinges on Sublocade’s momentum and market trends, though risks persist in litigation and earnings.

The Pharmaceutical Benefits Scheme (PBS) has introduced a groundbreaking treatment for Australians suffering from treatment-resistant depression. Starting May 1, Spravato, a ketamine-based nasal spray ...

A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...